share_log

Positive Earnings Growth Hasn't Been Enough to Get CHTC Helon (SZSE:000677) Shareholders a Favorable Return Over the Last Five Years

Positive Earnings Growth Hasn't Been Enough to Get CHTC Helon (SZSE:000677) Shareholders a Favorable Return Over the Last Five Years

創業板長遠的盈利增長並沒有讓股東在過去的五年獲得足夠的回報
Simply Wall St ·  06/13 18:21

It's nice to see the CHTC Helon Co., Ltd. (SZSE:000677) share price up 25% in a week. But if you look at the last five years the returns have not been good. You would have done a lot better buying an index fund, since the stock has dropped 21% in that half decade.

CHTC恒龍股份有限公司(SZSE:000677)在一週內上漲了25%,很不錯。但是,如果你看過去五年,回報並不好。由於這支股票在過去的五年中下跌了21%,購買指數基金會更好。

While the last five years has been tough for CHTC Helon shareholders, this past week has shown signs of promise. So let's look at the longer term fundamentals and see if they've been the driver of the negative returns.

雖然過去五年對於CHTC恒龍的股東來說是艱難的,但上週出現了一些跡象表明,長期的基本面可能是負回報的驅動因素。

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

儘管市場是一個強大的定價機制,股價不僅反映了基本業務表現,還反映了投資者的情緒。通過比較每股收益(EPS)和股價變化,並隨時間推移這樣做,我們可以了解股東對公司的態度如何隨時間變化。

While the share price declined over five years, CHTC Helon actually managed to increase EPS by an average of 79% per year. So it doesn't seem like EPS is a great guide to understanding how the market is valuing the stock. Or possibly, the market was previously very optimistic, so the stock has disappointed, despite improving EPS.

儘管股價下跌了五年,但CHTC恒龍實際上設法提高了每股收益,平均每年增長79%。因此,EPS似乎不是了解市場如何評估該股票的好指南。或者可能是市場此前非常樂觀,因此股票雖有所改善,但仍未達到預期。增加與股價相反,營業收入在五年期內每年實際上增長了8.7%。因此,似乎必須更仔細地查看基本面,以了解爲什麼股價相對較低。畢竟,可能存在機會。

It is unusual to see such modest share price growth in the face of sustained EPS improvements. We can look to other metrics to try to understand the situation better.

儘管EPS持續改善,但股價增長平緩是不尋常的現象。我們可以查看其他指標來更好地了解情況。

In contrast to the share price, revenue has actually increased by 8.7% a year in the five year period. So it seems one might have to take closer look at the fundamentals to understand why the share price languishes. After all, there may be an opportunity.

SZSE:000677的收益和營收增長分別於2024年6月13日。

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

下圖顯示了收益和營收隨時間變化的情況(如果你點擊圖像,可以看到更多細節):

earnings-and-revenue-growth
SZSE:000677 Earnings and Revenue Growth June 13th 2024
很高興看到CHTC恒龍在過去12個月中以5.1%的股東總回報率回饋股東。尤其是五年的年化TSR每年虧損4%與近期股價表現相比非常不利。長期的虧損使我們謹慎,但短期的TSR增長確實暗示着更美好的未來。

You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

你可以在這個免費的互動圖表中看到它的資產負債表如何隨着時間的推移而加強(或削弱)。

A Different Perspective

不同的觀點

It's good to see that CHTC Helon has rewarded shareholders with a total shareholder return of 5.1% in the last twelve months. Notably the five-year annualised TSR loss of 4% per year compares very unfavourably with the recent share price performance. The long term loss makes us cautious, but the short term TSR gain certainly hints at a brighter future. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For example, we've discovered 1 warning sign for CHTC Helon that you should be aware of before investing here.

我發現從長遠來看股價作爲業務績效的代理非常有趣。但爲了獲得真正的洞察力,我們還需要考慮其他信息。例如,在投資這裏之前,我們已經發現了1個CHTC恒龍的警示信號,你應該知道。

We will like CHTC Helon better if we see some big insider buys. While we wait, check out this free list of undervalued stocks (mostly small caps) with considerable, recent, insider buying.

如果我們看到一些大量內部買入,我們更喜歡CHTC恒龍。在等待期間,請查看這個免費的弱市股票(大部分爲小市值公司)的低估股票列表,其中包含相當多的最近內部買入。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論